Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men.

To identify the biological covariates of microalbuminuria (albuminuria >/=15 microg/min) in nondiabetic subjects, brachial blood pressure, echocardiographic left ventricular mass, and other cardiovascular and metabolic parameters were evaluated in 211 untreated males (38 normal controls, 109 uncomplicated stage 1 to 3 essential hypertensives, and 64 patients with clinically stable atherosclerotic peripheral vascular disease either with [n=44] or without [n=20] essential hypertension) with normal cardiac and renal function. Compared with normoalbuminuric subjects, microalbuminuric subjects (n=67) were characterized by higher systolic blood pressure, comparable diastolic blood pressure, and, therefore, wider pulse pressure. Greater prevalence of hypertension, peripheral vascular disease, left ventricular hypertrophy, and reduced HDL cholesterol values further distinguished microalbuminuric from normoalbuminuric subjects in univariate comparisons. The risk of microalbuminuria increased by ascending pulse pressure quintiles in age-corrected logistic regression models, in which pulse pressure was more predictive than systolic pressure and was independent of mean pressure. When microalbuminuric status was regressed against a series of dichotomous (vascular and active smoker status) and continuous (age, pulse and mean pressure, left ventricular mass index, and HDL and LDL cholesterol) variables, only pulse pressure, left ventricular mass index, and smoking status were independent predictors. The association of increased albuminuria with wider pulse pressure, a correlate of the pulsatile hemodynamic load and conduit vessel stiffness as well as an important cardiovascular risk factor, may explain why microalbuminuria predicts cardiovascular events in nondiabetic subjects. The independence from concomitant vascular disease also suggests that wider pulse pressure, rather than representing a simple marker for atherosclerotic disease, influences albuminuria directly.

[1]  F. Mosca,et al.  Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[2]  D. Levy,et al.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. , 1998, Journal of the American College of Cardiology.

[3]  J. Blacher,et al.  Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. , 1999, Hypertension.

[4]  K. Borch-Johnsen,et al.  Ambulatory blood pressure and urinary albumin excretion in clinically healthy subjects. , 1998, Hypertension.

[5]  L. Bouter,et al.  Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[6]  M. Safar,et al.  Pulse pressure in sustained essential hypertension: a haemodynamic study. , 1987, Journal of hypertension.

[7]  J. Potter,et al.  Pulse pressure and resistance artery structure in the elderly. , 1995, Hypertension.

[8]  B. Kasiske,et al.  American Indian heritage and risk factors for renal injury. , 1998, Kidney international.

[9]  S P Glasser,et al.  Vascular compliance and cardiovascular disease: a risk factor or a marker? , 1997, American journal of hypertension.

[10]  M. Cirillo,et al.  Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. , 1998, Archives of internal medicine.

[11]  S. Bandinelli,et al.  Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men. , 1998, Hypertension.

[12]  S. Pede,et al.  Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. , 1998, Hypertension.

[13]  R. Bigazzi,et al.  Association between hyperlipidemia and microalbuminuria in essential hypertension. , 1999, Kidney international. Supplement.

[14]  R. Bigazzi,et al.  Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension , 1998, Journal of hypertension.

[15]  J. Breyer,et al.  Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. , 1997, Kidney international.

[16]  M. Laakso,et al.  Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. , 1995, Circulation.

[17]  P. Ganz,et al.  Systemic nature of endothelial dysfunction in atherosclerosis. , 1995, The American journal of cardiology.

[18]  P. Whelton,et al.  The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence. , 1996, Journal of human hypertension.

[19]  K. Borch-Johnsen,et al.  Urinary albumin excretion in a population based sample of 1011 middle aged non-diabetic subjects. The Copenhagen City Heart Study Group. , 1993, Scandinavian journal of clinical and laboratory investigation.

[20]  J. Halimi,et al.  Albuminuria in normals and essential hypertension. , 1994, Journal of diabetes and its complications.

[21]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[22]  L. Bouter,et al.  Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. , 1998, Kidney international.

[23]  G. London,et al.  Atherosclerosis and arteriosclerosis in chronic renal failure. , 1997, Kidney international.

[24]  B. Howard,et al.  Prevalence of peripheral arterial disease and associated risk factors in American Indians: the Strong Heart Study. , 1999, American journal of epidemiology.

[25]  M. Safar,et al.  Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. , 1998, Hypertension.

[26]  M. Safar,et al.  Systolic blood pressure revisited. , 1997, Journal of the American College of Cardiology.

[27]  C. Reid,et al.  Left ventricular mass and microalbuminuria: relation to ambulatory blood pressure. Hypertension Diagnostic Service Investigators. , 1999, Clinical and experimental pharmacology & physiology.

[28]  K. Borch-Johnsen,et al.  Urinary albumin excretion in a population based sample of 1011 middle aged non-diabetic subjects , 1993 .

[29]  T. Ishimitsu,et al.  Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. , 1996, Hypertension.

[30]  G. Dell'omo,et al.  Microalbuminuria and endothelial dysfunction in essential hypertension , 1994, The Lancet.

[31]  C. Mogensen,et al.  Microalbuminuria as predictor of increased mortality in elderly people. , 1990, BMJ.

[32]  R. Asmar,et al.  Large artery stiffness in hypertension , 1997, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[33]  D. Levy,et al.  Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.

[34]  B. Fagerberg,et al.  Risk Factors That Predict Development of Microalbuminuria in Treated Hypertensive Men , 1996, Angiology.

[35]  D. Jacobs,et al.  Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study. , 1997, American journal of epidemiology.

[36]  K. Borch-Johnsen,et al.  Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals , 1997, Journal of Human Hypertension.

[37]  M. Criqui,et al.  The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease , 1998, Vascular medicine.

[38]  C. Jackson,et al.  MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.

[39]  C. Reid,et al.  LEFT VENTRICULAR MASS AND MICROALBUMINURIA: RELATION TO AMBULATORY BLOOD PRESSURE , 1999 .

[40]  M. Safar,et al.  Increased Pulse Pressure in Patients with Arteriosclerosis Obliterans of the Lower Limbs , 1987, Arteriosclerosis.

[41]  J. McMurray,et al.  The effect of atrial natriuretic factor on urinary albumin and beta 2-microglobulin excretion in man. , 1988, Journal of hypertension.